Authors


Malcolm H. Lader, MD, PhD

Latest:

Hypnotics

Several classes of hypnotic medication are available: the older barbiturates and their derivatives; benzodiazepines; chemically distinct “z-compounds”; antihistamines and antihistaminic antidepressants; and melatoninergic compounds. The use of hypnotic medications continues at a high rate. However, some switching to the shorter-acting benzodiazepines has occurred. The z-compounds-eszopiclone, zolpidem, and zaleplon-have become popular; they seem to have fewer residual effects than the benzodiazepines. Even so, care is needed in prescribing such hypnotics for the elderly.


Malcolm P. Rogers, MD

Latest:

Anxiety in the Medical Patient

Anxiety is a ubiquitous, natural affective state that is essential for evolutionary survival. Nearly as common, however, are experiences of anxiety that exceed social, psychological, or physiological needs, leading to functional impairment. Indeed, primary anxiety disorders, including panic disorder, social phobia, and generalized anxiety disorder (GAD), represent the most common category of mental illness in the United States. Secondary, or reactive, anxiety is also widespread and can arise not only from numerous medical causes but also from the psychological process of coping with illness.


Malkah Notman, MD

Latest:

College Students Under Stress

Emerging adults in the midst of a tremendous emotional growth spurt and a leap of neurocognitive maturation often need guidance articulating what bothers them.


Malkah T. Notman, MD

Latest:

Gender Differences and Psychiatric Disorders

Gender is an important variable in medicine and psychiatry. The initial interest in gender issues was stimulated by recognition that women were absent from much medical research. Now, however, the field has expanded to include more specific and sensitive attention to men and the role of gender and gender differences.


Mallay Occhiogrosso, MD

Latest:

Contraception and Misconceptions

Psychiatrists who treat women and adolescent girls may find it necessary to discuss with their patients reproductive planning and the role of contraception in setting comprehensive treatment goals. Here's why.


Mallay Ochiogrosso, MD

Latest:

Can You Trust Your Physician?

Statutes in 8 states are not designed to assure informed decision-making, say these psychiatrists; instead they represent an unprecedented effort by the government to use physician communications as an instrument for discouraging pregnant women from exercising their constitutional right to make their own reproductive choices.


Mani N. Pavuluri, MD, PhD

Latest:

The State of the Evidence on Pediatric Bipolar Disorder

Pediatric bipolar disorder (PBD) is a serious psychiatric illness that impairs children’s emotional, cognitive, and social development. PBD causes severe mood instability that manifests in chronic irritability, episodes of rage, tearfulness, distractibility, grandiosity or inflated self-esteem, hypersexual behavior, a decreased need for sleep, and behavioral activation coupled with poor judgment. While research in this area has accelerated during the past 15 years, there are still significant gaps in knowledge concerning the prevalence, etiology, phenomenology, assessment, and treatment for PBD.


Manish Saran, MD

Latest:

Biological Markers and the Future of Early Diagnosis and Treatment in Schizophrenia

Biological Markers and the Future of Early Diagnosis and Treatment in Schizophrenia


Manjola Ujkaj, MD, PhD

Latest:

Dementia, Agitation, and Aggression: The Role of Electroconvulsive Therapy

What role might electroconvulsive therapy play for short-term treatment of agitation and aggression in patients with dementia?


Manpreet K. Singh, MD, MS

Latest:

New Findings Related to Childhood-Onset Psychopathology

Innovative approaches that advance our understanding of the mechanisms that confer risk for psychiatric illness in youths is the focus.


Mantosh J. Dewan, MD

Latest:

Podcast: Brief Dynamic Therapy-5 Tenets to Maximize Effectiveness

In this podcast, Dr Mantosh Dewan, discusses strategies to help you and your patient get the most benefit from this form of therapy.


Manuel Mota-castillo, MD

Latest:

Are We Over-Diagnosing ADHD Based on “Hyperactivity"?

Here’s why ADHD is a diagnosis of exclusion.


Manuel Sanchez De Carmona, MD

Latest:

Lessons Learned From the International Society for Bipolar Disorders Task Force on Suicide

What is the actual risk of suicide attempts or suicide death in people with bipolar disorder? How does a BD diagnosis affect short-term and long-term suicide risk? How should a BD diagnosis help guide us toward the most effective suicide prevention strategies?


Marc Andrews, MD

Latest:

Early Evaluation and Management of Mild Traumatic Brain Injury

mild traumatic brain injury, MTBI, concussion, post-concussive syndrome


Marc D. Feldman, MD

Latest:

The Case of Factitious Disorder Versus Malingering

Patients who exaggerate, feign, or induce physical illness are a great challenge to their physicians. Trained to trust their patients’ self-reports, even competent and conscientious physicians can fall victim to these deceptions.


Marc E. Agronin, MD

Latest:

The Age of Cannabis Has Arrived: Issues for Older Adults

Cannabis use has prompted symptoms such as dizziness, sleepiness, and fatigue in older patients. Are there any benevolent effects?


Marc Fisher, MD

Latest:

Stroke: While Current Treatment Is Limited, New Options Are on the Horizon

Current therapy for acute ischemic stroke remains limited to intravenous recombinant tissue plasminogen activator (tPA) administered within 3 hours of symptom onset, but despite strong evidence supporting its effectiveness,1-5 only 2% to 4% of all stroke patients currently receive tPA.


Marc N. Potenza, MD, PhD

Latest:

Co-occurring Substance Use and Eating Disorders

What does existing research say about the connection between substance use disorders and eating disorders?


Marc-André Roy, MD, MSc

Latest:

Treating Comorbid Anxiety Disorders in Patients With Schizophrenia: A New Pathway

Identifying comorbid anxiety disorders as potential treatment targets may contribute to more positive outcomes for patients with schizophrenia. Details here.


Marcel D. Waldinger, MD, PhD

Latest:

New Insights in Premature Ejaculation

Ejaculatio praecox, or premature (rapid, early) ejaculation (PE), is a prevalent male sexual complaint. It may be part of the normal ejaculation variability in men, but it may also be the symptom of an ejaculatory dysfunction.


Marcello A. Maviglia, MD, MPH

Latest:

Alcohol and Drug Abuse Intervention in the Emergency Department

If done properly, the assessment of alcohol and substance use disorders in the emergency department (ED) or psychiatric emergency service can be the first step toward recovery.


Marcelo E. Bigal, MD, PhD

Latest:

Headache and Psychiatric Comorbidity

Migraine affects approximately 12% of the population, and a high percentage of these patients have comorbid psychiatric disorders. Knowing more about the interaction between headache and psychiatric factors can assist in evaluating and treating these patients.


Marcia Kraft Goin, MD

Latest:

Borderline Personality Disorder: Splitting Countertransference

Splitting, archetypally imbedded in a patient's psychic structure, acts as a powerful unconscious force to protect against the ego's perception of dangerous anxiety and intense affects. Rather than providing real protection, splitting leads to destructive behavior and turmoil in patients' lives.


Marcia Morris, MD

Latest:

Clinical Care of the Suicidal College Student: When and How to Involve Parents

Twenty years ago, it was rare for college students to mention suicidal thoughts, and even more rare to involve parents in their care. Today, students are more likely to describe suicidal ideation, necessitating a more thorough safety assessment with potential outreach to parents.


Marcia Valenstein, MD

Latest:

Common Augmentation Strategies for Depression: Findings Show Lack of Evidence

It is estimated that at least half of persons who begin antidepressant treatment will not respond to monotherapy.


Marco A. Ramos, BA

Latest:

Serving the Underserved: Who Needs Mental Health Care?

Experts address specific concerns when treating the immigrant sector and describe supervised mental health services for uninsured, largely undocumented patients.


Marco Mula, MD, PhD

Latest:

Epilepsy and Seizures: Neuropsychiatric Implications

Psychiatric comorbidity in epilepsy represents not only a matter of intellectual interest but also an important variable that affects prognosis in terms of morbidity and mortality.


Marcus Westerman, MD

Latest:

Atypical Antipsychotics for Treatment of Schizophrenia Spectrum Disorders

The number of prescriptions for antipsychotic treatment of teenagers has increased sharply in office-based medical practice. Adolescents with psychotic symptoms frequently present for clinical evaluation, and early-onset schizophrenia spectrum disorders (onset of psychotic symptoms before the age of 18 years) represent an important consideration in the differential diagnosis in these youths


Margaret A. Henderson, MD

Latest:

Treatment of Insomnia in Anxiety Disorders

How often do insomnia and anxiety disorders coexist? And how best to treat patients with comorbid insomnia and anxiety? Answers here..


Margaret G. O'connor, PhD

Latest:

Can Your Older Patient Drive Safely?

Medical professionals may be reluctant to initiate a discussion about driving with older patients in anticipation of a negative impact on the physician-patient relationship.

© 2025 MJH Life Sciences

All rights reserved.